← Leaderboards
Anuj Chauhan
Colorado School Of Mines
$1,144,418
Attributed
$2,288,836
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $954.8K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$2,288,836 · 3
By mechanism
R01$1,418,537 · 1
R21$870,299 · 2
Top collaborators
- Uday B Kompella7 shared
Others in their field
Other Rising Stars on “Design”
- Richard Smith · Medical Device Innovation Consortium$41,401,350
- Jeffrey Leintz · National Opinion Research Center$38,969,238
- Rhea Coler · Seattle Children'S Hospital$35,184,139
- Julia Louise Moore Vogel · Scripps Research Institute, The$32,252,685
- Christina Millin · Rho Federal Systems Division, Inc.$31,828,916
- Sabrina Paganoni · Massachusetts General Hospital$30,895,527
Research focus
DesignDevicesDrug Delivery SystemsContact LensesManufactureLensOryctolagus CuniculusCorneaPharmaceutical PreparationsNovel StrategiesIn VivoIn VitroInsightHydrophilic Contact LensesHydrogelsMathematical ModelDropsDrug KineticsEyedropsFrequenciesHourBiocompatible MaterialsBiological AvailabilityAnimal Model
Grant awards (7)
Back of the eye drug delivery: Novel contact lenses, pathways, and in-silico modeling$468,554
R01 · FY2025 · EY · contact PI
Nanobarrier contact lenses for mono and combination therapy for treating microbial keratitis$192,375
R21 · FY2025 · EY · contact PI
Unidirectional delivery of heat to the eyelid by GoldInLens$191,653
R21 · FY2025 · EY · contact PI
Back of the eye drug delivery: Novel contact lenses, pathways, and in-silico modeling$468,554
R01 · FY2024 · EY · contact PI
Nanobarrier contact lenses for mono and combination therapy for treating microbial keratitis$243,325
R21 · FY2024 · EY · contact PI
Unidirectional delivery of heat to the eyelid by GoldInLens$242,946
R21 · FY2024 · EY · contact PI
Back of the eye drug delivery: Novel contact lenses, pathways, and in-silico modeling$481,429
R01 · FY2023 · EY · contact PI